A brief history of barriers and the current state of diversity in clinical trials
Inclusive Design: Are your trials reflective of the patient population they aim to serve?
How can trials be more reflective of populations with disease?
How can we increase education and awareness to avoid patient bias and improve recruitment?
What are some other approaches to overcome barriers and extend the reach of trials to more diverse participants?
Unsupported Browser Detected
The browser you are using is not supported that will prevent you from accessing certain features of the website. We want you to have the best possible experience. For this you'll need to use a supported browser and upgrade to the latest version.